comprehensive -WSS

comprehensive

author：comprehensive 2025-08-04 03:41:46 - browse：1562

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Congress might make insulin pumps more accessible to the blind

WSS

Congress considering partial increase for doctor pay in Medicare

Influencer to be charged after chaos erupts in New York City's Union Square

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

For BCIs, commercial hurdles may be bigger than scientific ones

Bernie Sanders gets little from pharma CEOs on drug prices

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

focus

comprehensive

hotspot

Activists slam private health insurers over coverage restrictions

Why Eli Lilly’s earnings didn’t quite live up to the hype

Activists slam private health insurers over coverage restrictions

Having children helps parents live longer, especially after age 80

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

How to save PrEP access — and even expand it

Attacks on the drug industry will lead to fewer breakthroughs

Wikipedia

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Humana, CVS hope to turn members into patients at clinics

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Stem cell clinics for heart failure: buyer be wary

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

TytoCare raises $49 million to build out AI

hotspot

focus

focus

knowledge